Earnings History Data for Lexeo Therapeutics, Inc. (LXEO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Lexeo Therapeutics, Inc.
Lexeo Therapeutics is a clinical-stage genetic medicine company which defined cardiovascular diseases and APOE4-associated Alzheimer's disease are treated. Lexeo Therapeutics is based in New York City.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | PM | LXEO | Lexeo Therapeutics, Inc. | 263.00 | -0.89 | -0.65 | 0.00 | Lexeo Therapeutics GAAP EPS of -$0.89 misses by $0.24 [11/13/2024 11:10 AM] |
7.83 | 0.13 (1.76%) |
8.67 | 0.98 (12.74%) |
7.47 - 22.33 | 5,546,338 | 310,000 | 124,774 | ||
| 12-08-2024 | PM | LXEO | Lexeo Therapeutics, Inc. | 385.00 | -0.64 | -0.64 | 0.00 | Lexeo Therapeutics GAAP EPS of -$0.64 [8/12/2024 9:10 AM] |
11.84 | 0.34 (2.96%) |
0.0 | 0.0 (0.00%) |
9.00 - 22.33 | 95,116 | 330,000 | 0 | ||
| 09-05-2024 | PM | LXEO | Lexeo Therapeutics, Inc. | 442.00 | -0.77 | -0.76 | 0.00 | Lexeo Therapeutics reports Q1 results [5/9/2024 9:49 AM] |
14.44 | 0.72 (5.25%) |
0.0 | 0.0 (0.00%) |
9.00 - 22.33 | 225,907 | 150,000 | 0 | ||
| 11-03-2024 | PM | LXEO | Lexeo Therapeutics, Inc. | 391.00 | -0.86 | -0.71 | 0.00 | Lexeo Therapeutics GAAP EPS of -$0.86 misses by $0.15 [3/11/2024 10:12 AM] |
14.62 | -0.51 (-3.37%) |
15.40 | 0.27 (1.78%) |
9.00 - 22.33 | 245,009 | 80,000 | 26,193 | ||
| 11-12-2023 | PM | LXEO | Lexeo Therapeutics, Inc. | 327.00 | -12.36 | -0.90 | 0.00 | Lexeo Therapeutics GAAP EPS of -$12.36 misses by $11.46 [12/11/2023 10:45 AM] |
10.12 | -1.47 (-12.68%) |
0.0 | 0.0 (0.00%) |
9.00 - 17.72 | 67,765 | 130,000 | 0 | ||